Literature DB >> 12560869

Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis.

Janeane Hails1, Felicia Kwaku, A Peter Wilson, Geoff Bellingan, Mervyn Singer.   

Abstract

OBJECTIVE: Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in intensive care units in most countries. Despite recommendations for screening and isolation of patients with MRSA our perception has been that there is little uniformity in approach in ICUs besides adherence to basic infection control procedures. We thus sought to identify MRSA prevalence and the variation of infection control policy across intensive care units in England. DESIGN AND
SETTING: Postal questionnaire with telephone follow-up in English intensive care units. MEASUREMENTS AND
RESULTS: Responses were obtained from 217 (96%) ICUs. Marked variation in practice was noted in terms of patient screening, staff screening, infection control procedures, isolation or cohorting of colonised/infected patients, and ward discharge policy. Point prevalence data showed that 16.2% of ICU patients were known to be colonised or infected with MRSA. There was a regional bias, but no difference was noted between high and low prevalence regions in terms of unit demographics or infection control policies.
CONCLUSIONS: This study highlights the lack of consistent policy across English ICUs regarding isolation, screening and discharge practices for MRSA. Prospective studies are urgently needed to determine best practice.

Entities:  

Mesh:

Year:  2003        PMID: 12560869     DOI: 10.1007/s00134-003-1645-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

1.  Survival of enterococci and staphylococci on hospital fabrics and plastic.

Authors:  A N Neely; M P Maley
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?

Authors:  B Ostrowsky; J T Steinberg; B Farr; A H Sohn; R L Sinkowitz-Cochran; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  2001-02       Impact factor: 3.254

Review 3.  Can antibiotic-resistant nosocomial infections be controlled?

Authors:  B M Farr; C D Salgado; T B Karchmer; R J Sherertz
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

Review 4.  Decreased antimicrobial resistance after changes in antibiotic use.

Authors:  D W Smith
Journal:  Pharmacotherapy       Date:  1999-08       Impact factor: 4.705

5.  Trying to control MRSA causes more problems than it solves.

Authors:  S P Barrett; R V Mummery; B Chattopadhyay
Journal:  J Hosp Infect       Date:  1998-06       Impact factor: 3.926

6.  Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium.

Authors:  K E Byers; L J Durbin; B M Simonton; A M Anglim; K A Adal; B M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  1998-04       Impact factor: 3.254

7.  Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.

Authors:  J M Boyce; G Potter-Bynoe; C Chenevert; T King
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

8.  Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia.

Authors:  T V Riley; J W Pearman; I L Rouse
Journal:  Med J Aust       Date:  1995-10-16       Impact factor: 7.738

  8 in total
  5 in total

Review 1.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

2.  8th Annual Toronto Critical Care Medicine Symposium, 30 October-1 November 2003, Toronto, Ontario, Canada.

Authors:  Jeff Granton; John Granton
Journal:  Crit Care       Date:  2004-01-02       Impact factor: 9.097

3.  A new approach to Vancomycin utilization evaluation: A cross-sectional study in intensive care unit.

Authors:  Atefeh Mahmoodian; Saeed Abbasi; Shadi Farsaei
Journal:  J Res Pharm Pract       Date:  2016 Oct-Dec

4.  In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent.

Authors:  Parjam S Zolfaghari; Samantha Packer; Mervyn Singer; Sean P Nair; Jon Bennett; Cale Street; Michael Wilson
Journal:  BMC Microbiol       Date:  2009-02-04       Impact factor: 3.605

5.  Pro/con clinical debate: isolation precautions for all intensive care unit patients with methicillin-resistant Staphylococcus aureus colonization are essential.

Authors:  Barry M Farr; Geoffrey Bellingan
Journal:  Crit Care       Date:  2004-02-19       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.